These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2204006)

  • 1. [Combination therapy with adriamycin, cisplatin and vindesine in C cell carcinoma of the thyroid].
    Scherübl H; Raue F; Ziegler R
    Onkologie; 1990 Jun; 13(3):198-202. PubMed ID: 2204006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study.
    Scherübl H; Raue F; Ziegler R
    J Cancer Res Clin Oncol; 1990; 116(1):21-3. PubMed ID: 2312602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cisplatin, doxorubicin and vindesine in the treatment of advanced non-small cell lung cancer].
    Akiyama J; Sato A; Honda K; Chida K; Watanabe T; Okano H; Okano A; Taniguchi M; Genma H; Aoki H
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):419-24. PubMed ID: 1848420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial serum calcitonin concentrations to evaluate response to therapy of patients with medullary thyroid carcinoma.
    Athanassiades P; Piperingos G; Pandos P; Koutras D; Moulopoulos S
    Chemioterapia; 1988 Jun; 7(3):195-7. PubMed ID: 3168076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
    Hajje G; Borget I; Leboulleux S; Chougnet C; Al Ghuzlan A; Mirghani H; Caramella C; Hartl D; Schlumberger M; Baudin E
    Eur J Endocrinol; 2013 Feb; 168(2):113-8. PubMed ID: 23093698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma.
    Asakawa H; Kobayashi T; Komoike Y; Maruyama H; Nakano Y; Tamaki Y; Matsuzawa Y; Monden M
    Anticancer Res; 1997; 17(4A):2757-62. PubMed ID: 9252711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
    Wu LT; Averbuch SD; Ball DW; de Bustros A; Baylin SB; McGuire WP
    Cancer; 1994 Jan; 73(2):432-6. PubMed ID: 8293411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin combination chemotherapy in squamous cell carcinoma and adenoid cystic carcinoma of the skin.
    Ikegawa S; Saida T; Obayashi H; Sasaki A; Esumi H; Ikeda S; Kiyohara Y; Hayasaka K; Ishihara K
    J Dermatol; 1989 Jun; 16(3):227-30. PubMed ID: 2551943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.
    Kris MG; Gralla RJ; Wertheim MS; Kelsen DP; O'Connell JP; Burke MT; Fiore JJ; Cibas IR; Heelan RT
    Cancer Treat Rep; 1986 Sep; 70(9):1091-6. PubMed ID: 3527408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery.
    Jpn J Clin Oncol; 1995 Oct; 25(5):203-7. PubMed ID: 7474408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.
    Laure Giraudet A; Al Ghulzan A; Aupérin A; Leboulleux S; Chehboun A; Troalen F; Dromain C; Lumbroso J; Baudin E; Schlumberger M
    Eur J Endocrinol; 2008 Feb; 158(2):239-46. PubMed ID: 18230832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M; Kiura K; Okabe K; Toki H; Kimura M
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of octreotide in the treatment of medullary thyroid carcinoma.
    Frank-Raue K; Ziegler R; Raue F
    Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of soft tissue sarcomas in the adult with a combination of vindesine and cisplatin with doxorubicin or epirubicin: a pilot study].
    Becouarn Y; Bui BN; Kerbrat P; Chauvergne J; Brunet R; Robert J
    Bull Cancer; 1987; 74(2):109-16. PubMed ID: 3475140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.
    De Besi P; Busnardo B; Toso S; Girelli ME; Nacamulli D; Simioni N; Casara D; Zorat P; Fiorentino MV
    J Endocrinol Invest; 1991 Jun; 14(6):475-80. PubMed ID: 1723086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of mitomycin, vindesine, and cisplatin in the treatment of head and neck squamous cell carcinoma.
    Leyvraz S; Barrelet L; Savary M; Bernasconi S
    Cancer Treat Rep; 1987 Jan; 71(1):81-2. PubMed ID: 3791271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
    Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A
    Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial.
    Williams SD; Birch R; Einhorn LH
    Cancer Treat Rep; 1986 Mar; 70(3):405-7. PubMed ID: 3955552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant proliferating trichilemmal tumour and CAV (cisplatin, adriamycin, vindesine) treatment.
    Hayashi I; Harada T; Muraoka M; Ishii M
    Br J Dermatol; 2004 Jan; 150(1):156-7. PubMed ID: 14746636
    [No Abstract]   [Full Text] [Related]  

  • 20. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.